跳至主要内容
临床试验/NCT00941096
NCT00941096已完成4 期

Efficacy Of The Bimatoprost/Timolol Fixed Combination In Patients Treated With Bimatoprost for Primary Open Angle Glaucoma, Exfoliation Glaucoma or Ocular Hypertension.

Larissa University Hospital2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2009年7月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
Mean diurnal intraocular pressure

研究概览

简要总结

The purpose of this study is to examine the ocular hypotensive effect of Bimatoprost and the potential additional effect of the Bimatoprost/Timolol fixed combination in eyes with ocular hypertension, primary open angle glaucoma or exfoliation glaucoma.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary open angle glaucoma
  • Exfoliation glaucoma
  • Ocular hypertension

排除标准

  • Younger than 18 years old
  • Inability to understand and/or follow study requirements
  • Women of childbearing potential not using reliable birth control, pregnant or lactating women
  • History of chronic obstructive pulmonary disease, heart failure, 2nd or 3rd AV block
  • Anticipated modification of treatment for systemic hypertension during the study period
  • History of ocular herpes, corneal scarring, conventional or laser surgery or macular pathology
  • History of allergy, poor tolerability or poor response to study medication
  • Best corrected visual acuity less than 0.4
  • Significant visual field defect (MD<15.0 dB)

结局指标

主要结局

Mean diurnal intraocular pressure

时间窗: Five weeks on each medication

次要结局

未报告次要终点

研究者

发起方
Larissa University Hospital
申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Intraocular Pressure Reduction With the... | 临床试验